Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mapping CNS Changes to Frovatriptan Administration in Acute Treatment of Prodrome or Preventative Treatment of Menstrual Migraine (MM)

NCT01114711 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT01114711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01114711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mapping CNS Changes to Frovatriptan Administration in Acute Treatment of Prodrome or Preventative Treatment of Menstrual Migraine (MM)
Lead sponsor
Mclean Hospital
Phase
Observational
Overall status
Terminated
Start date
April 30, 2010
Completion date
May 31, 2010
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

frovatriptan, menstrual migraine